# Possibility to Stop Perdialytic Heparin Therapy in Hemodialysed Patients With HeprAN ™ Membrane and Treated by Long-term Anticoagulation With VKA

> **NCT04462614** · NA · UNKNOWN · sponsor: **CHU de Reims** · enrollment: 49 (estimated)

## Conditions studied

- Chronic Hemolysis
- VKA
- Anticoagulants / Administration & Dosage
- Coated Materials
- Biocompatible
- Heparin / Administration & Dosage
- Membranes Artificial
- Prospective Studies
- Renal Dialysis / Methods
- Renal Insufficiency / Therapy

## Interventions

- **DRUG:** Decrease per-dialytic heparin therapy

## Key facts

- **NCT ID:** NCT04462614
- **Lead sponsor:** CHU de Reims
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08
- **Primary completion:** 2021-01
- **Final completion:** 2021-07
- **Target enrollment:** 49 (ESTIMATED)
- **Last updated:** 2020-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04462614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04462614, "Possibility to Stop Perdialytic Heparin Therapy in Hemodialysed Patients With HeprAN ™ Membrane and Treated by Long-term Anticoagulation With VKA". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04462614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*